Daniel J. Rader

Daniel Rader is the Seymour Gray Professor of Molecular Medicine at the Perelman School of Medicine at the University of Pennsylvania. He serves as the chair of the department of genetics as well as the chief of the division of translational medicine and human genetics in the department of medicine and chief of the division of human genetics in pediatrics at Children’s Hospital of Philadelphia. He is also associate director of Penn’s Institute for Translational Medicine and Therapeutics and is co-director of the Penn Medicine Biobank.

Dr. Rader’s research focuses on the human genetics and functional genomics of lipoprotein metabolism and atherosclerosis, as well as the translational implications for novel therapeutic approaches. He has had a long interest in novel therapeutic approaches to unmet medical needs in the treatment of severe dyslipidemia. He led the scientific and clinical development of a first-in-class inhibitor of microsomal transfer protein for the treatment of homozygous familial hypercholesterolemia. He also has a particular interest in HDL metabolism and function, and novel approaches to targeting HDL metabolism and reverse cholesterol transport in the treatment, prevention, and regression of atherosclerosis.

Dr. Rader trained in internal medicine at Yale New Haven Hospital, and in human genetics and physiology of lipoprotein metabolism at the National Institutes of Health. He has been on the UPenn faculty since 1994. He is currently the deputy editor of the journal Arteriosclerosis, Thrombosis and Vascular Biology, the chief scientific advisor to the Familial Hypercholesterolemia Foundation, and serves on the board of directors of the International Society for Atherosclerosis, the board of external experts of the National Heart Lung and Blood Institute, and the advisory board for clinical research for the NIH. Dr. Rader has been elected to the American Society of Clinical Investigation, the Association of American Physicians, and the Institute of Medicine of the National Academy of Sciences (now the National Academy of Medicine).